Abstract
The reinforcing and discriminative stimulus effects of brotizolam, a benzodiazepine-hypnotic, were evaluated in rhesus monkeys. In one experiment, separate groups of monkeys (N=3/group) were trained to discriminate pentobarbital (10 mg/kg, IG) ord-amphetamine (0.56–1.0 mg/kg, IG) from saline, in a discrete-trials avoidance/escape paradigm. Pentobarbital (5.6–10 mg/kg), diazepam (1.0–1.7 mg/kg), and brotizolam (0.3–1.7 mg/kg) resulted in 100% drug-lever responding in all three pentobarbital-trained monkeys. Ind-amphetamine-trained monkeys brotizolam administration resulted only in saline-lever responding. In another experiment, monkeys were surgically prepared with indwelling intravenous catheters and lever pressing resulted in an injection of 0.1 mg/kg/injection sodium methohexital under a fixed-ratio 10 (FR 10) schedule. Pentobarbital (0.01–0.3 mg/kg/injection) and diazepam (0.003–0.10 mg/kg/injection) maintained responding above saline control levels when substituted for methohexital. Brotizolam (0.001–0.01 mg/kg/injection) resulted in more injections received compared to saline, but fewer injections compared to pentobarbital or diazepam. Thus, results from the present experiment suggest that brotizolam would have pentobarbital-like subjective effects. However, the abuse liability of brotizolam may be lower than that for diazepam.
Similar content being viewed by others
References
Ator NA, Griffiths RR (1983) Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788. J Pharmacol Exp Ther 226: 776–782
Ator NA, Griffiths RR (1987) Self-administration of barbiturates and benzodiazepines: a review. Pharmacol Biochem Behav 27:391–398
Ator NA, Griffiths RR (1989) Asymmetrical cross-generalization in drug discrimination with lorazepam and pentobarbital training conditions. Drug Dev Res 16:355–364
Barrett JE, Witkin JM (1990) Buspirone in animal models of anxiety. In Tunnicliff G, Eison AS, Taylor DP (eds), Buspirone: mechanisms and clinical aspects. Academic Press, New York (in press)
Bergman J, Johanson CE (1985) The reinforcing properties of diazepam under several conditions in the rhesus monkey. Psychopharmacology 86:108–113
Bertalmio AJ, Medzihradsky F, Winger G, Woods JH (1990) Differential influence ofn-dealkylation on the stimulus properties of some opioid agonists. J Pharmacol Exp Ther (in press)
Böke-Kuhn K, Danneberg P, Kuhn FJ, Lehr E (1986) Antiemotional and anticonvulsant activity of brotizolam and its effects on motor performance in animals. Arzneimittelforschung 36:528–531
Corrodi H, Fuxe K, Lidbrink P, Olson L (1971) Minor tranquilizers, stress and central catecholamine neurons. Brain Res 29:1–16
Deneau G, Yanagita T, Seevers MH (1969) Self-administration of psychoactive substances by the monkey. Psychopharmacology 16:30–48
Goldberg SR, Hoffmeister RF, Schlichting UU, Wuttke W (1971) A comparison of pentobarbital and cocaine self-administration in rhesus monkeys: effects of dose and fixed-ratio parameter. J Pharmacol Exp Ther 179:277–283
Griffiths RR, Bigelow GE, Henningfield JH (1980) Similarities in animal and human drug-taking behavior. In: Mello NK (ed) Advances in substance abuse, vol. 1. JAI Press, Greenwich, Connecticut pp: 1–90
Griffiths RR, Lukas SE, Bradford LD, Brady JV, Snell J (1981) Self-injection of barbiturates and benzodiazepines in baboons. Psychopharmacology 75:101–109
Griffiths RR, Roache JD, Ator NA, Lamb RJ, Lukas SE (1985) Similarities in reinforcing and discriminative stimulus effects of diazepam, triazolam, and pentobarbital in animals and humans. In: Seiden LS, Balster RL (eds) Behavioral pharmacology: the current status. Liss, New York, pp 419–432
Herling S, Valentino RJ, Winger GD (1980) Discriminative stimulus effects of pentobarbital in pigeons. Psychopharmacology 71:21–28
Holtzman SG (1982) Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey. Psychopharmacology 77:295–300
Ishiko J, Inagaki C, Takaori S (1983) Inhibitory effects of brotizolam, a new thienodiazepine, on limbic forebrain and neostriatal dopaminergic systems in vivo and in vitro. Neuropharmacology 22:221–226
Johanson CE, Woolverton WL, Schuster CR (1987) Evaluating laboratory models of drug dependence. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 1617–1625
Langley MS, Clissold SP (1988) Brotizolam. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as an hypnotic. Drugs 35:104–122
Lehr E, Böke-Kuhn D, Danneberg P (1986) Therapeutic safety studies of brotizolam in animals. Arzneimittelforschung 36:532–533
Mamelak M, Csima A, Price V (1983) Effects of brotizolam on sleep of chronic insomniacs. Br J Clin Pharmacol 16:377S-382S
Mamelak M, Csima A, Buck L, Price V (1989) A comparative study on the effects of brotizolam and flurazepam on sleep and performance in the elderly. J Clin Psychopharmacol 9:260–267
Mandelli M, Tognoni G, Garattini S (1978) Clinical pharmacokinetics of diazepam. Clin Pharmacokinet 3:72–91
Nielsen EB, Scheel-Krüger J (1988) Central nervous system stimulants: Neuropharmacological mechanisms. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer Heidelberg New York, Berlin, pp 57–72
Rall TW, Schleifer LS (1980) Drugs effective in the therapy of the epilepsies. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 6th edn. Macmillan, New York, pp 448–474
Rickels K (1986) The clinical use of hypnotics: indications for use and the need for a variety of hypnotics. Acta Psychiat Scand [Suppl. 332] 74:132–141
Rickels K, Morris R, Mauriello R, Rosenfeld H, Chung E (1986) Brotizolam, a triazolo, thieno-diazepine in insomnia. Clin Pharmacol Ther 40:293–299
Roehrs T, Zonick F, Koshoret G, Wittig R, Roth T (1983) Effects of acute administration of brotizolam in subjects with disturbed sleep. Br J Clin Pharmacol 16:371S-376S
Sepinwall J, Cook L (1978) Behavioral pharmacology of antianxiety drugs. In: Iversen LL, Iversen SD, Snyder SH (ed) Handbook of psychopharmacology, vol. 13. Plenum Press, New York, pp 345–393
Stockhaus K, Bechtel WD (1986) Physical dependence capacity of brotizolam in rhesus monkeys. Arzneimittelforschung 36:597–600
Ueki S, Watanabe S, Yamamoto T, Shibata S, Shibata K (1984) Behavioral effects of brotizolam, a new thienotriazolodiazepine derivative. Jpn J Pharmacol 35:287–299
Velasco M, Velasco F, Cepeda C, Romo R, Perez-Toledo M (1981) Effect of a new thienodiazepine (WE941) on sleep patterns of normal and insomniac subjects. Neuropharmacology 20:461–468
Winger G, Herling S (1982) Discriminative stimulus effects of pentobarbital in rhesus monkeys: tests of stimulus generalization and duration of action. Psychopharmacology 76:172–176
Winger G, Stitzer ML, Woods JH (1975) Barbiturate-reinforced responding in rhesus monkeys: comparison of drugs with different durations of action. J Pharmacol Exp Ther 195:505–514
Woods JH (1983) Experimental abuse liability assessment of benzodiazepines. J Psychoactive Drugs 15:61–65
Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Pharmacol Rev 39:251–413
Woolverton WL, Nader MA (1990) Methods for studying the reinforcing effects of drugs. In: Adler MW (ed) Testing and evaluation of drugs of abuse. Liss, New York, pp 165–192
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nader, M.A., Winger, G., Woods, J.H. et al. Discriminative and reinforcing effects of brotizolam in rhesus monkeys. Psychopharmacology 103, 166–171 (1991). https://doi.org/10.1007/BF02244198
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02244198